SEI Investments
DICE

SEI Investments’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

SEI Investments’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,771
Closed -$305K – 2747
2022
Q4 		$305K Buy
+9,771
New +$319K ﹤0.01% 2188

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

SEI Investments's DICE Position: Q1 2023 in Review

SEI Investments sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q1 2023, closing a stake of 9,771 shares — an estimated $305K sold.

SEI Investments first reported a position in DICE in Q4 2022 and held it in 1 quarter. The position peaked at $305K in Q4 2022. 115 funds tracked by Wall St. Rank hold DICE as of Q1 2023.

  • SEI Investments reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • SEI Investments sold 9,771 DICE Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $305K.
  • SEI Investments first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • SEI Investments's DICE Therapeutics, Inc. Common Stock position peaked at $305K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q1 2023.

Based on SEI Investments's 13F filing for Q1 2023, filed 12 May 2023.